Julia James

Featured in: Favicon

dallasnews.com Favicon

dailykos.com Favicon

graphicpolicy.com Favicon

hottytoddy.com Favicon

northsidesun.com Favicon

jacksonadvocateonline.com Favicon

onlinelibrary.wiley.com

Articles

Hemocompatibility‐Related Adverse Events Associated With or Without Low Molecular Weight Heparin Bridging in Outpatients With a HeartMate 3 Left Ventricular Assist Device

2 months ago | onlinelibrary.wiley.com | Julia James |Madeline P Fuller |Madison Hunt |Elizabeth E. Powell

Background Prior studies of anticoagulation bridging during periods of low International Normalized Ratio (INR) in outpatients with a durable, continuous flow left ventricular assist device (CF-LVAD) have shown a variable impact on thrombotic and bleeding events. These studies include predominantly older devices such as the HeartMate 2 (HM2) and HeartWare HVAD, which are known to experience more overall thrombotic events than the HeartMate 3 (HM3) device.

Contact details

Emails

[email protected]

Socials & Sites

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →